RxDoctor Payments DataLook up a doctor →

Sahil Khera

Hospitalist · Burlington, MANPI 1871809020

Payments from drug & device makers

$506,163in general payments, 2019–2025

Across 721 payments — averaging $702.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$170K
  • Medtronic$136K
  • Essential Medical, Inc.$82K
  • Arrow International, Inc.$72K
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$18K
  • Edwards Lifesciences$17K
  • plus $10K from 20 others
$2,838in research payments, 2019–2025

Across 2 payments — averaging $1419.01 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medtronic$2K
  • Terumo Medical Corporation$838

What the payments were for

  • Consulting fees$32,55014%
  • Speaking & faculty fees$138,35761%
  • Travel & lodging$27,29412%
  • Food & beverage$27,99112%
  • Other$1760%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$506,163 in reported general payments places this provider in the 95th percentile of 599 hospitalist providers in Massachusetts.

See all hospitalist providers in Massachusetts

Medicare billing

Part B allowed, 2024
$145,627
Medicare patients
676
Services billed
1,591

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban36$37,633
JardianceEmpagliflozin29$35,517
EntrestoSacubitril/Valsartan19$24,494
Atorvastatin Calcium42$412
Metoprolol Succinate32$403
Amlodipine Besylate74$329
Isosorbide Mononitrate ErIsosorbide Mononitrate24$322
Pantoprazole Sodium11$193
Metoprolol Tartrate27$156
Losartan Potassium16$152
Furosemide27$134
ClopidogrelClopidogrel Bisulfate22$128
Lisinopril24$113
Spironolactone17$79
Carvedilol12$56

Paid to pharmacies, not to this prescriber.

Other hospitalist in Burlington

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →